Inhibitor of apoptosis proteins and apoptosis

被引:99
|
作者
Wei, Yunbo [1 ]
Fan, Tingjun [1 ]
Yu, Miaomiao [1 ]
机构
[1] Ocean Univ China, Coll Marine Life Sci, Dept Marine Biol, Qingdao 266003, Peoples R China
关键词
inhibitor of apoptosis proteins; apoptosis; baculovirus IAP repeat; IAP antagonist;
D O I
10.1111/j.1745-7270.2008.00407.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis is a physiological cell death process that plays a critical role in development, homeostasis, and immune defense of multicellular animals. Inhibitor of apoptosis proteins (IAPs) constitute a family of proteins that possess between one and three baculovirus IAP repeats. Some of them also have a really interesting new gene finger domain, and can prevent cell death by binding and inhibiting active caspases, but are regulated by IAP antagonists. Some evidence also indicates that IAP can modulate the cell cycle and signal transduction. The three main factors, IAPs, IAP antagonists, and caspases, are involved in regulating the progress of apoptosis in many species. Many studies and assumptions have been focused on the anfractuous interactions between these three main factors to explore their real functional model in order to develop potential anticancer drugs. In this review, we describe the classification, molecular structures, and properties of IAPs and discuss the mechanisms of apoptosis. We also discuss the promising significance of clinical applications of IAPs in the diagnosis and treatment of malignancy.
引用
收藏
页码:278 / 288
页数:11
相关论文
共 50 条
  • [41] Osthole induces lung cancer cell apoptosis through inhibition of inhibitor of apoptosis family proteins
    Xu, Xiao-Man
    Zhang, Man-Li
    Zhang, Yi
    Zhao, Li
    ONCOLOGY LETTERS, 2016, 12 (05) : 3779 - 3784
  • [42] Targeted suppression of inhibitor of apoptosis proteins amplifies apoptosis and improves response to enzalutamide in prostate cancer
    Pilling, Amanda
    Hwang, Ok
    Hwang, Clara
    CANCER RESEARCH, 2016, 76
  • [43] Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies
    S Fulda
    Leukemia, 2012, 26 : 1155 - 1165
  • [44] Regulation of inhibitor of apoptosis proteins after traumatic brain injury
    Lotocki, G
    Dong, J
    Alonso, OF
    Truettner, JS
    Bramlett, HM
    Dietrich, WD
    Keane, RW
    JOURNAL OF NEUROTRAUMA, 2003, 20 (10) : 1102 - 1102
  • [45] Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres
    Cohen, Frederick
    Koehler, Michael F. T.
    Bergeron, Philippe
    Elliott, Linda O.
    Flygare, John A.
    Franklin, Matthew C.
    Gazzard, Lewis
    Keteltas, Stephen F.
    Lau, Kevin
    Ly, Cuong Q.
    Tsui, Vickie
    Fairbrother, Wayne J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2229 - 2233
  • [46] Assembling the building blocks: structure and function of inhibitor of apoptosis proteins
    P D Mace
    S Shirley
    C L Day
    Cell Death & Differentiation, 2010, 17 : 46 - 53
  • [47] Purification and use of recombinant inhibitor of apoptosis proteins as caspase inhibitors
    Deveraux, QL
    Welsh, K
    Reed, JC
    APOPTOSIS, 2000, 322 : 154 - 161
  • [48] Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
    de Graaf, AO
    de Witte, T
    Jansen, JH
    LEUKEMIA, 2004, 18 (11) : 1751 - 1759
  • [49] Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors
    Vucic, Domagoj
    CURRENT CANCER DRUG TARGETS, 2008, 8 (02) : 110 - 117
  • [50] Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes
    Sylwia Gradzka
    Oliver S. Thomas
    Oliver Kretz
    Aladin Haimovici
    Lazaros. Vasilikos
    Wendy Wei-Lynn Wong
    Georg Häcker
    Ian E. Gentle
    Cell Death & Disease, 9